TECH
$274.01
Bio-Techne Cp
$7.26
2.72%
TECH
Earnings Whisper ®
N/A
4th Quarter June 2020
Consensus:  $0.57
Revenue:  $162.44 Mil
Thursday
Jul 30
6:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Thursday, April 30, 2020

What do you expect when TECH reports earnings?
Beat
Meet
Miss

Where is TECH's stock price going from here?
Up
Flat
Down
Stock chart of TECH
Analysts
Summary of analysts' recommendations for TECH
Score
Grade
Pivots
Resistance
$284.41
$280.04
$277.03

$272.66

Support
$269.65
$265.28
$262.27
Tweet
Growth
Description
Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits; and clinical diagnostic immunoassay kits. The Company also offers flow cytometry products; natural and synthetic chemical compounds; hematology controls and calibrators; and hematology control products. Bio-Techne Corporation, formerly known as Techne Corporation, is headquartered in Minneapolis, Minnesota.
Peers
BiogenAmgenGilead SciencesNeurocrine BiosciencesSeattle GeneticsBluebird BioQiagen N.V.RepligenNovavaxSangamo Therapeutics